GE Healthcare Discovery IGS 730 Cardiovascular X-Ray Imaging System. The angiography X-ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular and non-vascular, diagnostic and interventional procedures. Additionally, with the OR table, the angiographic X-ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for image guided surgical procedures. The OR table is suitable for interventional and surgical procedures.
Publicado el 25 de septiembre de 2013 · Inicio del retiro: 19 de junio de 2013
Resumen
FDA registra el retiro Z-2253-2013 de dispositivos médicos de Clase II, publicado el 25 de septiembre de 2013 e iniciado el 19 de junio de 2013. Empresa responsable: GE Healthcare, LLC; Estado: Finalizado; Cantidad reportada: 4 (2 US, 2 OUS); Lote: Mfg Lot or Serial # 00000611882BU2 00000612803BU7 00000613979BU4 00000620447BU3. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
GE Healthcare has recently become aware of a potential safety issue with respect to Discovery IGS 730 Imaging Systems. A patient data management error may prevent the Discovery IGS 730 Imaging System from booting on start-up or re-booting during procedure. The boot issue may occur when a large amount of patient data remains in the browser and is not deleted. The inability to boot the system ma
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- GE Healthcare, LLC
- Distribuidor
- Worldwide distribution: US (nationwide) including states of : PA and TN; countries of: FRANCE and SINGAPORE.
- Lote
- Mfg Lot or Serial # 00000611882BU2 00000612803BU7 00000613979BU4 00000620447BU3
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDACentricity PACS Software Version 7.0 SP0.0.4.73 de agosto de 2022
- FDASIGNA Premier magnetic resonance scanner, model 5748519.27 de julio de 2022
- FDAGE Centricity Universal Viewer Zero Footprint. To view, communicate, process, and display Medical images and13 de julio de 2022
- FDABack up batteries in Avance CS2 and Avance CS2 Pro anesthesia devices manufactured on or after April 1, 20196 de julio de 2022
- FDACentral Dressing Change Kit; AMS-8464CP- 6. Vygon Central Dressing Change Kit contains: 1 Pair Nitrile Gloves25 de septiembre de 2013
- FDAPOWERWAND Safety Introducer with Extended Dwell Catheter; Catalog no. 92006. Used to gain access to the25 de septiembre de 2013
Preguntas sobre este retiro
¿GE Healthcare Discovery IGS 730 Cardiovascular X-Ray Imaging System. The angiography X-ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular and non-vascular, diagnostic and interventional procedures. Additionally, with the OR table, the angiographic X-ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for image guided surgical procedures. The OR table is suitable for interventional and surgical procedures. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2253-2013 el 25 de septiembre de 2013. Peligro reportado: GE Healthcare has recently become aware of a potential safety issue with respect to Discovery IGS 730 Imaging Systems. A patient data management error may prevent the Discovery IGS 730 Imaging System from booting on start-up or re-booting during procedure. The boot issue may occur when a large amount of patient data remains in the browser and is not deleted. The inability to boot the system ma
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter